XML 41 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Jun. 27, 2015
Jun. 28, 2014
Cash flows from operating activities    
Net income $ 174,355 $ 187,716
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 41,553 28,998
Equity compensation expense 12,506 8,154
Deferred income taxes 1,623 (905)
Amortization of deferred rent 502 1,537
Loss on disposal of fixed assets 631 738
Amortization of deferred financing costs 187 187
Tax benefits on exercise of share options (8,332) (18,686)
Foreign currency losses 624 305
Loss (income) earned on joint venture 907 (203)
Change in assets and liabilities:    
Receivables, net 112,510 85,970
Inventories (80,627) (99,958)
Prepaid expenses and other current assets (5,393) (4,020)
Other assets 2,030 (190)
Accounts payable 29,174 10,186
Accrued expenses and other current liabilities (6,063) 13,950
Other long-term liabilities 3,484 8,606
Net cash provided by operating activities 279,671 222,385
Cash flows from investing activities    
Capital expenditures (105,998) (73,187)
Purchase of intangible assets (7,399) (4,504)
Equity method investments (907) 0
Net cash used in investing activities (114,304) (77,691)
Cash flows from financing activities    
Repurchase of treasury shares (351,095) (1,037)
Tax benefits on exercise of share options 8,332 18,686
Exercise of employee share options 4,946 5,173
Net cash (used in) provided by financing activities (337,817) 22,822
Effect of exchange rate changes on cash and cash equivalents 2,068 3,060
Net (decrease) increase in cash and cash equivalents (170,382) 170,576
Beginning of period 978,922 971,194
End of period 808,540 1,141,770
Supplemental disclosures of cash flow information    
Cash paid for interest 190 173
Cash paid for income taxes 61,351 51,170
Supplemental disclosure of noncash investing and financing activities    
Accrued capital expenditures $ 25,610 $ 24,212